Efficacy and safety of intracoronary pro-urokinase injection during percutaneous coronary intervention in treating ST elevation myocardial infarction patients: a systematic review and meta-analysis of randomized controlled trials.
Yin XS, Huang YW, Li ZP, Dong JL, Zou JM, Tian L, Yang J.
Eur Rev Med Pharmacol Sci. 2022 Aug;26(16):5802-5813. doi: 10.26355/eurrev_202208_29518.
Intracoronary injection of tirofiban prevents microcirculation dysfunction during delayed percutaneous coronary intervention in patients with acute myocardial infarction.
Sun Z, Zeng J, Huang H.
Int J Cardiol. 2016 Apr 1;208:137-40. doi: 10.1016/j.ijcard.2016.01.204. Epub 2016 Jan 23.
Intracoronary arterial retrograde thrombolysis with percutaneous coronary intervention: a novel use of thrombolytic to treat acute ST-segment elevation myocardial infarction.
Tian JW, Zhu M, Wang FQ, Li K, Zhou CF, Li B, Wang M, Deng JL, Jiang B, Bai J, Guo Y, Jin RJ, Zhang Z, Lin Y, Wang JH, Zhao SH, Shen MZ.
J Geriatr Cardiol. 2019 Jun;16(6):458-467. doi: 10.11909/j.issn.1671-5411.2019.06.004.
Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase.
Kelly RV, Crouch E, Krumnacher H, Cohen MG, Stouffer GA.
Catheter Cardiovasc Interv. 2005 Nov;66(3):327-32. doi: 10.1002/ccd.20521.
Kounis syndrome with Samter-Beer triad treated with intracoronary adrenaline.
Ihdayhid AR, Rankin J.
Catheter Cardiovasc Interv. 2015 Nov 15;86(6):E263-7. doi: 10.1002/ccd.25960. Epub 2015 Aug 10.
Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H, Schindler K, Friedenberger J, Eitel I, Fürnau G, Grebe E, Erbs S, Linke A, Möbius-Winkler S, Kivelitz D, Schuler G.
Circulation. 2008 Jul 1;118(1):49-57. doi: 10.1161/CIRCULATIONAHA.107.747642. Epub 2008 Jun 16.
Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes: A meta-analysis of randomized controlled trials.
Sun B, Liu Z, Yin H, Wang T, Chen T, Yang S, Jiang Z.
Medicine (Baltimore). 2017 Oct;96(40):e8223. doi: 10.1097/MD.0000000000008223.
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction.
Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H.
Thromb Res. 2012 Nov;130(5):765-8. doi: 10.1016/j.thromres.2011.11.045. Epub 2011 Dec 20.
Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Kırma C, Erkol A, Pala S, Oduncu V, Dündar C, İzgi A, Tigen K, Gibson CM.
Catheter Cardiovasc Interv. 2012 Jan 1;79(1):59-67. doi: 10.1002/ccd.23109. Epub 2011 Nov 30.
Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction.
Markis JE, Malagold M, Parker JA, Silverman KJ, Barry WH, Als AV, Paulin S, Grossman W, Braunwald E.
N Engl J Med. 1981 Oct 1;305(14):777-82. doi: 10.1056/NEJM198110013051401.
